{
    "medicine_id": "64758bb3f62f1c482ed2a63cc0b046033f2e8814",
    "platform_id": "DB05481",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v Recombinant alpha 1 antitrypsin",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in alpha 1 antitrypsin deficiency atopic dermatitis and chronic obstructive pulmonary disease COPD",
            "contraindications": {
                "disease": "Well tolerated in clinical trials",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Alpha 1 antitrypsin is a glycoprotein primarily produced by hepatocytes and to a lesser extent immune system cells Recombinant alpha 1 antitrypsin rAAT is produced from yeast which unlike commercially available forms of plasma derived AAT eliminates the risk associated with blood borne infectious agents and allows for a increased manufacturing rAAT belongs to a family of structurally related proteins classified as serine protease inhibitors or SERPINS which are known to inhibit several proteases including trypsin cathepsin G thrombin tissue kallikrein as well as neutrophil elastase The proteinase antiproteinase balance is believed to be important for maintaining healthy skin",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}